In support of this, elevated expression of EP300 in hepatocellular carcinomas (HCC) correlates with enhanced vascular invasion, intrahepatic metastasis, shortened survival, and, strikingly, low E-Cadherin expression [75]. Here, EP300 is linked to hepatocellular carcinoma.